Tamoxifen affects PLCg1 expression in ER plus breast cancer cells

被引：0
|
作者：
Vergne, Ralphdy [1 ]
Ortiz, Carmen [2 ]
Godoy, Lenin [2 ]
Matta, Jaime [2 ]
机构：
[1] Univ Puerto Rico Ponce, Biol, Ponce, PR USA
[2] Ponce Hlth Sci Univ, Basic Sci, Ponce, PR USA
来源：
FASEB JOURNAL | 2016年 / 30卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
936.2
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Reversal of tamoxifen resistance by artemisinin in ER plus breast cancer: bioinformatics analysis and experimental validation
    Zhuo, Zhili
    Zhang, Dongni
    Lu, Wenping
    Wu, Xiaoqing
    Cui, Yongjia
    Zhang, Weixuan
    Zhang, Mengfan
    ONCOLOGY RESEARCH, 2024, 32 (06) : 1093 - 1107
  • [42] Modulation of BAG-1 Expression Alters the Sensitivity of Breast Cancer Cells to Tamoxifen
    Liu, Hong
    Lu, Su
    Gu, Lin
    Gao, Yongchang
    Wang, Tong
    Zhao, Jing
    Rao, Jianyu
    Chen, Jun
    Hao, Xishan
    Tang, Shou-Ching
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2014, 33 (02) : 365 - 374
  • [43] REQUIREMENT FOR PHOSPHOLIPASE C GAMMA 1 (PLCG1) IN DEVELOPMENT AND MAINTENANCE OF HEMATOPOIETIC STEM- AND PROGENITOR CELLS
    Arreba-Tutusaus, P.
    Schnoeder, T.
    Fischer, T.
    Heidel, F. H.
    HAEMATOLOGICA, 2015, 100 : 452 - 452
  • [44] Estrogen Receptor Alpha Negative (ER-) Breast Cancer Stem Cells in ER plus Cell Lines and Primary Cancers Are Enriched by Tamoxifen Therapy
    O'Brien, C. S.
    Howell, S. J.
    Gandhi, A.
    Gee, J.
    Lykkesfeldt, A.
    Nicholson, R. I.
    Clarke, R. B.
    CANCER RESEARCH, 2010, 70
  • [45] Tamoxifen Resistance in Estrogen Receptor Positive (ER plus ) Breast Cancer Is Driven by Estrogen Receptor Negative (ER-) Cancer Stem-Like Cells.
    O'Brien, C. S.
    Howell, S. J.
    Gee, J.
    Lykkesfeldt, A. E.
    Nicholson, R., I
    Clarke, R. B.
    CANCER RESEARCH, 2009, 69 (24) : 807S - 807S
  • [46] Effects of Stealth Liposomal Daunorubicin Plus Tamoxifen on the Breast Cancer and Cancer Stem Cells
    Guo, Jia
    Zhou, Jie
    Ying, Xue
    Men, Ying
    Li, Ruo-Jing
    Zhang, Yan
    Du, Ju
    Tian, Wei
    Yao, Hong-Juan
    Wang, Xiao-Xing
    Ju, Rui-Jun
    Lu, Wan-Liang
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2010, 13 (02): : 136 - 151
  • [47] Gene expression profiling of BRCA1-mutant human breast cancer cells after exposure to tamoxifen plus estrogen.
    Murphy, CD
    Olshen, AB
    Chuai, S
    Viale, A
    Kim, SW
    Borgen, PI
    Hudis, C
    Boyd, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 864S - 864S
  • [48] Which one is the best for breast cancer; tamoxifen plus hyperthermia or tamoxifen plus radiotherapy?
    Joveini, Z.
    Behrouzkia, Z.
    Zohdiaghdam, R.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S21 - S21
  • [49] FEN1 is a prognostic biomarker for ER plus breast cancer and associated with tamoxifen resistance through the ERα/cyclin D1/Rb axis
    Xu, Lu
    Shen, Ji-Ming
    Qu, Jing-Lei
    Song, Na
    Che, Xiao-Fang
    Hou, Ke-Zuo
    Shi, Jing
    Zhao, Lei
    Shi, Sha
    Liu, Yun-Peng
    Qu, Xiu-Juan
    Teng, Yue-E
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (03)
  • [50] ERβ2 and ERβ5 inhibit proliferation and promote Tamoxifen-sensitivity of breast cancer cells
    Feldmann, C.
    Liu, H.
    Kratz, A.
    Mieth, M.
    Eucker, J.
    Possinger, K.
    Elstner, E.
    Zang, C.
    ONKOLOGIE, 2010, 33 : 119 - 119
12345